.

Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

MAXALT Drug Profile

« Back to Dashboard
Maxalt is a drug marketed by Merck and is included in two NDAs. It is available from six suppliers.

The generic ingredient in MAXALT is rizatriptan benzoate. There are twenty-two drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the rizatriptan benzoate profile page.

Summary for Tradename: MAXALT

Patents:0
Applicants:1
NDAs:2
Suppliers / Packagers: see list6
Drug Prices: :see details

Clinical Trials for: MAXALT

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Merck
MAXALT
rizatriptan benzoate
TABLET;ORAL020864-001Jun 29, 1998RXNo
Merck
MAXALT-MLT
rizatriptan benzoate
TABLET, ORALLY DISINTEGRATING;ORAL020865-002Jun 29, 1998RXYes
Merck
MAXALT
rizatriptan benzoate
TABLET;ORAL020864-002Jun 29, 1998RXYes
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: MAXALT

These historical archives are available as an add-on to one-year subscriptions.
See the Signup Form for more information.

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Merck
MAXALT
rizatriptan benzoate
TABLET;ORAL020864-001Jun 29, 19985,298,520*PED<disabled>
Merck
MAXALT
rizatriptan benzoate
TABLET;ORAL020864-002Jun 29, 19985,602,162*PED<disabled>
Merck
MAXALT
rizatriptan benzoate
TABLET;ORAL020864-002Jun 29, 19985,298,520*PED<disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for: MAXALT

Drugname Dosage Strength RLD Submissiondate
rizatriptan benzoateOrally Disintegrating Tablets5 mg and 10 mgMaxalt-MLT2/17/2006
rizatriptan benzoateTablets5 mg and 10 mgMaxalt9/2/2004
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc